Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (844)	10/30/2003 11:11:58 AM
From: keokalani'nui	Read Replies (1) \| Respond to of 1005

Add CancerVax. CNVX.

To: keokalani'nui who wrote (844)	12/6/2003 12:27:24 PM
From: Jibacoa	Respond to of 1005

According to San Mateo County Times, GTOP is the only one trading above its IPO price from the group of biotechnology companies that had their IPO this fall. The fact that the deal was done at a lower price than originally planned may have helped the stock.<g> "The average company stock is down 13 percent from its IPO price among those eight biotech firms that burst out of the gate this fall." sanmateocountytimes.com siliconinvestor.com Bernard